A research team from the Center for Safe Medication Practice and Research (CSMPR), Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) conducted the world's first systematic ...
Sep 6, 2022
0
12
Seasonal changes in light—longer days in summer, shorter in winter—have long been associated with human behaviors, affecting everything from sleep and eating patterns to brain and hormonal activity. Seasonal affective ...
Sep 5, 2022
0
197
Children at familial high risk (FHR) for schizophrenia have neurocognitive impairments compared with population-based controls (PBCs), according to a study recently published in JAMA Psychiatry.
Aug 23, 2022
0
4
A joint research team of Daegu Gyeongbuk Institute of Science and Technology professors Um Ji-won and Ko Jae-won of the Department of Brain Sciences reported a new genetic mutation related to intellectual disability and discovered ...
Aug 11, 2022
0
126
Individuals with severe mental illness or type 2 diabetes mellitus (T2DM) have increased levels of peripheral immune-inflammatory biomarkers, which may contribute to neurocognitive and social deficits, according to a study ...
Aug 11, 2022
0
2
A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients' insulin resistance, according to a small-scale clinical trial.
Jul 27, 2022
0
22
The largest ever genomic study of pneumonia has identified the genetic risk signals of the disease, paving the way for potential new treatments and the use of precision medicine.
Jul 6, 2022
0
65
A first-of-its kind study published in Schizophrenia Research looked at how demographic factors might play a different role in the development of non-affective psychosis (e.g. schizophrenia) when compared to affective psychosis ...
Jul 6, 2022
0
4
Smoking increases the risk of developing schizophrenia by between 53% and 127% and of developing depression by 54% to 132%, a report by academics from the University of Bristol published today has shown. More research is ...
Jun 20, 2022
0
26
Valproic acid—a drug used to treat epilepsy, migraine, and bipolar disorder—can cause birth defects when taken during pregnancy. Now, a study publishing June 14 in the open access journal PLOS Biology by Bill Keyes of ...
Jun 14, 2022
0
350
